glp-1 alzheimer's drugs show promise in treatment despite trial setback | Zain Khalpey, MD, PhD, FACS posted on the topic The potential mechanisms of GLP-1

Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating [PMID: 26692333] Laboratory literature summary: Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling

A non-greasy hydrating facial serum for everyday skincare

R., & Badawy, S

doi: 10.1016/S0140-6736(14)60976-4 110 UmpierrezGTof PovedanoSPrez ManghiFShurzinskeLPechtnerV

Many clients report feeling more productive and less dependent on caffeine

SureNanos interest in formulation and delivery technologies within these emerging areas aligns with the companys broader emphasis on drug-delivery innovation and platform flexibility